Nanoviricides (NNVC) EPS (Basic) (2010 - 2026)
Nanoviricides (NNVC) posted EPS (Basic) of -$0.09 for Q1 2026, up 16.49% sequentially from -$0.11 in Q4 2025, and up 33.06% YoY from -$0.07 in Q1 2025.
Nanoviricides (NNVC) EPS (Basic) (2010 - 2026) Analysis & Trends
Nanoviricides has reported EPS (Basic) for 17 years, with the latest figure at -$0.09 in Q1 2026.
- Quarterly EPS (Basic) rose 33.06% year-over-year to -$0.09 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$0.38 (up 38.55% YoY) and the FY2025 annual result came in at -$0.64, up 11.82% from the prior year.
- EPS (Basic) grew to -$0.09 in Q1 2026 per NNVC's latest filing, from -$0.11 in the prior quarter.
- Over five years, EPS (Basic) peaked at -$0.09 in Q1 2026 and troughed at -$1.01 in Q4 2022.
- A 5-year average of -$0.31 and a median of -$0.16 in 2024 frame the typical range for EPS (Basic).
- The sharpest annual moves came in 2023 and 2024: EPS (Basic) plunged 543.14% in 2023, then surged 83.78% in 2024.
- Over 5 years, EPS (Basic) stood at -$1.01 in 2022, then surged by 81.4% to -$0.19 in 2023, then advanced by 24.49% to -$0.14 in 2024, then rose by 20.39% to -$0.11 in 2025, then rose by 16.49% to -$0.09 in 2026.
- According to Business Quant data, EPS (Basic) over the past three periods registered -$0.09, -$0.11, and -$0.11 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 1.23 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -0.72 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.06 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.18 |
| 10 | Nanoviricides | 28.74 Mn | 25.53 Mn | - | -0.09 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.09 |
| Dec 31, 2025 | -0.11 |
| Sep 30, 2025 | -0.11 |
| Jun 30, 2025 | -0.14 |
| Mar 31, 2025 | -0.14 |
| Dec 31, 2024 | -0.14 |
| Sep 30, 2024 | -0.23 |
| Jun 30, 2024 | -0.20 |
| Mar 31, 2024 | -0.16 |
| Dec 31, 2023 | -0.19 |
| Sep 30, 2023 | -0.17 |
| Jun 30, 2023 | -0.32 |
| Mar 31, 2023 | -1.00 |
| Dec 31, 2022 | -1.01 |
| Sep 30, 2022 | -0.91 |
| Jun 30, 2022 | -0.15 |
| Mar 31, 2022 | -0.16 |
| Dec 31, 2021 | -0.17 |
| Sep 30, 2021 | -0.23 |
| Jun 30, 2021 | -0.19 |